![]() Other Issues: |
Contents: Volume 22, Supplement 1 May 2007
[Index by Author]
|
||||
| |
|||||
| Malignancy in renal transplantation: opportunities with proliferation signal inhibitors | |||||
This supplement has been sponsored by an unrestricted educational grant from Novartis Pharma AG, Basel, Switzerland |
|||||
| |
|||||
Table of Contents (PDF)
